Correlation Between Neurobo Pharmaceuticals and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Carmell Therapeutics, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Carmell Therapeutics.
Diversification Opportunities for Neurobo Pharmaceuticals and Carmell Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neurobo and Carmell is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Carmell Therapeutics
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.49 times more return on investment than Carmell Therapeutics. However, Neurobo Pharmaceuticals is 2.04 times less risky than Carmell Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 256.00 in Neurobo Pharmaceuticals on September 13, 2024 and sell it today you would lose (30.00) from holding Neurobo Pharmaceuticals or give up 11.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Carmell Therapeutics
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| Carmell Therapeutics |
Neurobo Pharmaceuticals and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Carmell Therapeutics
The main advantage of trading using opposite Neurobo Pharmaceuticals and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Carmell Therapeutics vs. Sensient Technologies | Carmell Therapeutics vs. Hudson Technologies | Carmell Therapeutics vs. Xiabuxiabu Catering Management | Carmell Therapeutics vs. NL Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |